Unilabs to acquire Blufstein, one of the largest independent and accredited laboratories in Peru
Geneva, Lima, 7th August 2017. Unilabs announced today an agreement to acquire Blufstein, one of the top 3 accredited and private laboratories in Peru, for an undisclosed amount.
With a network of 31 collection centres and 4 hospital labs, Blufstein has acquired a strong reputation in the health market over the last decades and has become an ideal partner for organic growth.
"With 50 years in the Peruvian Market, Blufstein is a respected company with first-class services, an excellent reputation and strong customer relationships," said Fernando de Górgolas, General Manager International Business at Unilabs. "This acquisition allows us to expand our services’ portfolio and extend our reach into the Peruvian private healthcare market. We see this operation as a positive and necessary step toward granting our customers of their lasting access to state-of-the-art services – now and far into the future."
“Jacobo and Nathan Blufstein, Chairmen of Blufstein, said: "We are very happy to join forces with Unilabs, because we share the same values: to put our patients at the heart of what we do and to be a strong, steadfast and value-adding partner in the long run."
The finalisation of the deal is subject to approval by the relevant regulatory authorities.
For further information or to arrange an interview with Unilabs, please contact Pauline Kropp at email@example.com or +41 22 909 77 94
With over 199 laboratories and 44 imaging units and a broad catalogue of more than 2,500 diagnostic tests, Unilabs is one of Europe’s leading providers of clinical laboratory testing and medical diagnostic imaging services. Headquartered in Geneva, Switzerland the Unilabs Group serves private and public healthcare providers, local governments, pharmaceutical companies and the general public. The company employs more than 6,900 people worldwide, successfully operates laboratory and medical diagnostic imaging facilities in 14 countries, and generates annual revenues of €800m in 2016. Its network of facilities provides its customers with one of the broadest geographic footprints of any clinical laboratory and medical diagnostic services provider in Europe.
We are at the heart and start of all effective treatment decisions!
Founded by Jacobo Blufstein in 1955, Blufstein is one of the largest independent and accredited labs in Peru. It is based in Lima, where it runs one core lab, 31 collection centres, and four hospital labs. Blufstein has been constantly investing in sustaining its quality standards and establishing a customer centric service culture under the leadership of Jacobo and Nathan Blufstein. The company holds the ISO 9001:2008 certification; it is accredited for Biosecurity Level III, by the Center of Disease Control to test for lead, cadmium and mercury and by the College of American Pathologists.